DiaGen AI / Team
100+ years of combined experience across AI, ML, drug discovery, clinical regulation and capital markets — spanning Canada, the U.S., the UK, EU and UAE.
Brian D. KeaneCEO, Chairman30+ yrs legal + capital markets, $3B+ transactions. Ex-Banker Rodman & Renshaw and Ladenburg Thalmann. Former MD, Yorkville Advisors. JD 2000, NYLS, Certification AI drug discovery, 2023, MIT.
Paolo LoboPresident / COOMSc Biochemistry (UBC). 10+ yrs in IVD, crystallography + biotech across business development, regulatory strategy and partnerships. Formerly at Sino Biological + Published in Nature.
Andrew ChanCFOFinance and operations leader for early-stage startups. Former Finance Manager at Electronic Arts; Head of Finance at Xtract AI.
Mohit PandeyChief AI OfficerAI/ML for life sciences, widely published. PhD Bioinformatics (UBC), MS in CS (Rutgers). Formerly Recursion (Nasdaq: RXRX) and Weill Cornell.
Eric BaumCo-Founder / Director20+ yrs advising private + public companies. Co-Founder Solidea Capital, Director Acquis Consulting. Corporate Board Governance Expert. Board Member, Starton Holdings. Valedictorian, Emory U.
Noah El Rimawi-FineML EngineerMaster's at McGill and Mila researching ML for drug discovery, biomolecular design and genetics. BSc Mathematics and Computer Science.
Ivan SemenovComputational Drug DesignMSc Bioorganic Chemistry (summa cum laude). 4+ yrs in pharma as a computational chemist with Insilico Medicine, Boston Gene. Leads CADD and AI-driven molecule and peptide design.
Dr. Sonny KohliDirector, Chief Medical AdvisorMD FRCPC. Chief Med Info Officer, Brockville Hospital. Member, Royal College of Physicians. Prof. McMaster Univ. Co-founder, Cloud DX. Winner of Canada's XPRIZE. Former VP, Roche. Astronaut candidate, CSA.
Aditya TallapragadaAdvisorFounder of AKT Health. 15+ yrs in life sciences and clinical research, applying AI and deeptech to regulatory workflows. Built Impakt Health, a Japan-certified Class II SaMD.
Mike GrantisAdvisor8+ yrs investing in liquid tokens and private ventures. Co-Founder, Contango Digital Assets + CEO General Tensor. Founder, Crypto Weekly. Associate, Satstreet.
Paul CrathDirector / Legal AdvisorFormerly at White & Case. Currently Partner and Head of Capital Markets at CMX Law, New York. 30+ yrs in capital markets, M&A and cross-border transactions. Bar: New York.
Neil CrabbAdvisorCEO of Frontier IP Group (AI/IP focus) and former founding shareholder of Exscientia. Co-founded Sigma Capital, with prior investment management experience in private banking and Equitable Life.
For platform access, catalog partnering or co-development enquiries.
IR@diagen.ai